News Daily News Matrimonio relacionado con mejores resultados de la PCI Yael L. Maxwell September 27, 2013
News Daily News Meta Análisis: A las Mujeres les Va Mejor que a los Hombres tras una TAVR a pesar de tener Más Complicaciones Yael L. Maxwell September 27, 2013
News Daily News Combination of Remote Pre- and Postconditioning Fails to Help Cardiac Surgery Patients Jason Kahn September 20, 2013
News Daily News Combinación de acondicionamiento a distancia previo y posterior no ayuda a pacientes con cirugía cardíaca Jason Kahn September 20, 2013
News Daily News Un Meta Análisis Sugiere que la Vitamina C Protege contra la Lesión Renal Aguda Caitlin E. Cox September 13, 2013
News Daily News Meta-analysis Suggests Vitamin C Protective Against Acute Kidney Injury Caitlin E. Cox September 13, 2013
News Daily News La Sensibilidad Baro-refleja podría ayuda a Localizar a Probables Respondedores a la Denervación Renal September 13, 2013
News Daily News Designation as ‘Unfit for Open Repair’ Predicts Worse EVAR Outcomes Leah Lawrence September 13, 2013
News Daily News Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation September 13, 2013
News Conference News ESC 2013 ESC Congress 2013: Mix of Trials with Potential to Reshape Practice September 09, 2013
News Conference News ESC 2013 Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation Caitlin E. Cox September 04, 2013
News Conference News ESC 2013 PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk Yael L. Maxwell September 04, 2013
News Industry News Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System September 03, 2013
News Industry News Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry September 02, 2013
News Conference News ESC 2013 FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk Caitlin E. Cox September 02, 2013
News Conference News ESC 2013 ASSURE: RVX-208 Fails to Stall or Reverse CAD Progression vs. Placebo September 02, 2013
News Conference News ESC 2013 TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS Caitlin E. Cox September 01, 2013
News Daily News La EVAR Ambulatoria es una Opción para 1/3 parte de los Pacientes con AAA Yael L. Maxwell August 30, 2013
News Daily News Ambulatory EVAR an Option for One-Third of AAA Patients Yael L. Maxwell August 30, 2013